V65L (p.Val65Leu) variant of AGTR1 (Type-1 angiotensin II receptor)

V65L (p.Val65Leu) in AGTR1 (Type-1 angiotensin II receptor) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.24 / 1. The record also includes population frequency data and structural context.

V65L (p.Val65Leu) variant details